Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
500.4 CHF | +0.04% | +3.26% | +41.53% |
04.06. | Aktien Schweiz unverändert - Defensive Schwergewichte stützen | DJ |
29.05. | Aktien Schweiz etwas leichter - Anleger nehmen Gewinne mit | DJ |
Kurzporträt
- bio-pharmazeutische Produkte (52,6%): exklusive Synthesen, mikrobiologische Fermentierungsprodukte, Zellkulturen von Säugetieren, usw. ;
- Kapseln und Dosierungslösungen für Biopharmazeutika, Arzneimittel und Ernährungsprodukte an. (20,3%). Darüber hinaus bietet die Gruppe Nahrungsbestandteile;
- niedermolekulare Wirkstoffe (13,2%);
- Technologien und Plattformen zur Umsetzung der Herstellungsprozesse und der Produktion von Zell- und Gentherapien (11,1%);
- sonstige (2,8%).
Geographisch gesehen verteilt sich der Umsatz wie folgt: Schweiz (16%), Europa (29,8%), USA (38,8%), Nord- und Südamerika (3%), Japan (3,7%), China (2,6%), Asien (5,8%) und sonstige (0,3%).
Mitarbeiterzahl: 18 000
Umsatz nach Geschäftsbereich
CHF in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Biologics
55,4
%
| 3 274 | 52,6 % | 3 719 | 55,4 % | +13.59% |
Capsules & Health Ingredients
17,3
%
| 1 266 | 20,3 % | 1 161 | 17,3 % | -8.29% |
Small Molecules
13,4
%
| 819 | 13,2 % | 901 | 13,4 % | +10.01% |
Cell & Gene
10,4
%
| 693 | 11,1 % | 696 | 10,4 % | +0.43% |
Corporate/Eliminations
3,6
%
| 171 | 2,7 % | 240 | 3,6 % | +40.35% |
Umsatz je Region
CHF in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
31,8
%
| 2 415 | 38,8 % | 2 136 | 31,8 % | -11.55% |
Switzerland
17,4
%
| 996 | 16,0 % | 1 168 | 17,4 % | +17.27% |
Japan
8,1
%
| 227 | 3,6 % | 544 | 8,1 % | +139.65% |
Ireland
5,5
%
| 343 | 5,5 % | 368 | 5,5 % | +7.29% |
Belgium
5,1
%
| 302 | 4,9 % | 341 | 5,1 % | +12.91% |
Denmark
4,8
%
| 158 | 2,5 % | 322 | 4,8 % | +103.80% |
Germany
4,5
%
| 224 | 3,6 % | 302 | 4,5 % | +34.82% |
Rest of Europe
2,9
%
| 207 | 3,3 % | 195 | 2,9 % | -5.80% |
China
2,6
%
| 161 | 2,6 % | 172 | 2,6 % | +6.83% |
United Kingdom
2,5
%
| 139 | 2,2 % | 171 | 2,5 % | +23.02% |
Singapore
2,0
%
| 113 | 1,8 % | 137 | 2,0 % | +21.24% |
Sweden
1,8
%
| 143 | 2,3 % | 123 | 1,8 % | -13.99% |
France
1,7
%
| 116 | 1,9 % | 111 | 1,7 % | -4.31% |
South Korea
1,4
%
| 141 | 2,3 % | 97 | 1,4 % | -31.21% |
Canada
1,3
%
| 63 | 1,0 % | 90 | 1,3 % | +42.86% |
Netherlands
1,3
%
| 132 | 2,1 % | 88 | 1,3 % | -33.33% |
Brazil
1,1
%
| 49 | 0,8 % | 71 | 1,1 % | +44.90% |
Italy
0,8
%
| 41 | 0,7 % | 52 | 0,8 % | +26.83% |
India
0,6
%
| 42 | 0,7 % | 42 | 0,6 % | 0.00% |
Spain
0,6
%
| 41 | 0,7 % | 40 | 0,6 % | -2.44% |
Mexico
0,5
%
| 34 | 0,5 % | 33 | 0,5 % | -2.94% |
Rest of Asia
0,4
%
| 36 | 0,6 % | 29 | 0,4 % | -19.44% |
Rest of Latin America
0,4
%
| 38 | 0,6 % | 26 | 0,4 % | -31.58% |
Australia & New Zealand
0,2
%
| 21 | 0,3 % | 16 | 0,2 % | -23.81% |
Thailand
0,2
%
| 15 | 0,2 % | 15 | 0,2 % | 0.00% |
Indonesia
0,2
%
| 16 | 0,3 % | 14 | 0,2 % | -12.50% |
Czech Republic
0,2
%
| 7 | 0,1 % | 11 | 0,2 % | +57.14% |
Other Countries
0,0
%
| 2 | 0,0 % | 2 | 0,0 % | 0.00% |
Rest of North and Central America
0,0
%
| 1 | 0,0 % | 1 | 0,0 % | 0.00% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 25.04.17 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 01.12.21 |
Maria Nunez
COO | Chief Operating Officer | 55 | 01.08.22 |
Lyle Wheeler
IRC | Investor Relations Contact | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 16.04.14 |
Director/Board Member | 66 | 16.04.14 | |
Marion Helmes
BRD | Director/Board Member | 58 | 05.05.22 |
Albert Baehny
CEO | Chief Executive Officer | 72 | 25.04.17 |
Christoph Mäder
BRD | Director/Board Member | 64 | 26.04.16 |
Roger Nitsch
BRD | Director/Board Member | 63 | 01.05.22 |
Director/Board Member | 64 | 04.05.18 | |
Director/Board Member | 52 | 04.05.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 74 468 752 | 72 076 913 ( 96,79 %) | 2 352 163 ( 3,159 %) | 96,79 % |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
LONZA GROUP AG 3,16% | 2 352 163 | 3,16% | 1 268 183 853 $ |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Arch Protection Chemicals Pvt Ltd.
Arch Protection Chemicals Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Lonza Group AG, Arch Protection Chemicals Pvt Ltd. is an Indian company that provides business services. The company is based in Mumbai, India. |
Miscellaneous Commercial Services
|
Arch UK Biocides Ltd.
Arch UK Biocides Ltd. Household/Personal CareConsumer Non-Durables Part of Lonza Group AG, Arch UK Biocides Ltd. is a provider of integrated healthcare solutions to the pharmaceutical, biotech, and specialty ingredients markets. The company is based in Castleford, UK, and offers careers in various disciplines such as bioengineering and chemistry. Lonza optimizes scientific innovation and manufacturing technology to enable its customers to serve their patients and consumers. Lonza's quality management is committed to meeting all specifications and fulfilling customer needs and expectations. Founded in 2003, the British company's solutions aim to improve life quality by preventing illness, enabling healthier lifestyles, and supporting a safe environment. |
Household/Personal Care
|
Capsugel Italy SRL
Capsugel Italy SRL Miscellaneous Commercial ServicesCommercial Services Part of Chester Investor Holdings SRL, Capsugel Italy SRL provides management consulting services. The company is based in Milan, Italy. |
Miscellaneous Commercial Services
|
Hickson Ltd.
Hickson Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1937, Hickson Ltd. is a business consulting British company that provides consulting services. The company is based in Castleford, UK and is part of Lonza Group AG. |
Miscellaneous Commercial Services
|
Capsugel Hungary Kft
| |
Innovative Water Care Europe SAS
Innovative Water Care Europe SAS Specialty StoresRetail Trade Innovative Water Care Europe SAS manufactures basic organic chemicals. The company was founded on September 17, 1982 and is headquartered in Amboise, France. |
Specialty Stores
|
Capsugel France SAS
Capsugel France SAS Apparel/Footwear RetailRetail Trade Capsugel France SAS manufactures & distributes clothes and clothing accessories. The company was founded in 1970 and is headquartered in Colmar, France. |
Apparel/Footwear Retail
|
Capsugel Financeco SCA
Capsugel Financeco SCA Pharmaceuticals: MajorHealth Technology Part of Lonza Group AG, Capsugel Financeco SCA is a Luxembourger pharmaceutical company founded in 2011. The company manufactures pharmaceutical products and is based in Luxembourg, Luxembourg. |
Pharmaceuticals: Major
|
Capsugel Germany GmbH
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+41.53% | 40.25 Mrd. | |
+51.85% | 57.87 Mrd. | |
-5.25% | 39.94 Mrd. | |
-5.16% | 28.54 Mrd. | |
+12.79% | 26.4 Mrd. | |
-20.18% | 19.33 Mrd. | |
+30.88% | 12.4 Mrd. | |
+0.61% | 12.23 Mrd. | |
+25.06% | 12.2 Mrd. | |
-9.14% | 11.06 Mrd. |
- Börse
- Aktien
- 928619 Aktie
- Unternehmen Lonza Group AG